Doctor profile · Federal record
Dr. Salil Shukla, MD
Retina Specialist (Ophthalmology) Physician (CMS: Ophthalmology) · Ophthalmology Physician · Golden, CO
- NPI 1154595171
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 22 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
400 Indiana St Ste 310
Golden, CO 804015033
(303) 261-1600
fax (303) 261-1601 - Mailing address
-
8101 E Lowry Blvd Ste 210
Denver, CO 802307195
Credentials & registration
- NPI registered
- April 2008 — 18 yrs on file
- Profile last updated
- March 11, 2020
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207WX0107X — NUCC code
- State licenses (2)
- Colorado #49167 · Colorado #0049167
- Medicaid
- CO #10287566
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1154595171. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
28,773
Distinct HCPCS
10
Medicare allowed
$3,367,468
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 20,340 | 49 | $37 | |
92134 |
Imaging of retina | 2,137 | 644 | $42 | |
J0178 |
Injection, aflibercept, 1 mg | 2,026 | 188 | $871 | |
67028 |
Injection of drug into eye | 1,498 | 321 | $132 | |
J2781 |
Injection, pegcetacoplan, intravitreal, 1 mg | 1,005 | 27 | $151 | |
92014 |
Established patient complete exam of visual system | 720 | 478 | $131 | |
J7999 |
Compounded drug, not otherwise classified | 252 | 93 | $97 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 165 | 22 | $269 | |
92250 |
Photography of the retina | 123 | 110 | $38 | |
92004 |
New patient complete exam of visual system | 82 | 82 | $154 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 1,307. This provider delivers 22× the peer median.Open Payments
Industry payments received
All-time total
$1,164
Transactions
33
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genentech, Inc. | 2 | $400.79 | |
| Regeneron Healthcare Solutions, Inc. | 9 | $200.01 | |
| Astellas Pharma US Inc | 5 | $197.87 | |
| Genentech USA, Inc. | 8 | $169.53 | |
| Biogen, Inc. | 3 | $77.97 | |
| ABBVIE INC. | 3 | $59.83 | |
| Alimera Sciences, Inc. | 2 | $32.20 | |
| Apellis Pharmaceuticals, Inc. | 1 | $25.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
111
Patients
92
Total drug cost
$2,328
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 73 | 66 | $1,004 |
| Prednisolone Acetate | Generic | 38 | 26 | $1,324 |
Frequently asked questions
What is Dr. Salil Shukla's medical specialty?
Dr. Salil Shukla practices Retina Specialist (Ophthalmology) Physician in Golden, CO.
Where does Dr. Salil Shukla practice?
Dr. Salil Shukla practices at 400 Indiana St Ste 310, Golden, CO 804015033. Office phone: 3032611600.
What is Dr. Salil Shukla's NPI?
Dr. Salil Shukla's National Provider Identifier (NPI) is 1154595171, issued by NPPES.
Does Dr. Salil Shukla accept Medicare assignment?
Yes. Dr. Salil Shukla accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Salil Shukla commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection, aflibercept, 1 mg (HCPCS J0178). Source: CMS Medicare Physician & Other Practitioners file.